Mesenchymal stromal cells (MSCs) constitute a heterogeneous population of stromal cells
with immunomodulatory and regenerative properties that support their therapeutic use …

During the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
many critically ill patients died of severe pneumonia, acute respiratory distress syndrome …

Mesenchymal stromal cells (MSC) have immune regulatory and tissue regenerative
properties. MSCs are being studied as a therapy option for many inflammatory and immune …

The devastating global impact of the Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has prompted scientists to develop novel strategies to fight Coronavirus …

Severe acute respiratory syndrome coronavirus-2 and the related coronavirus disease-19
(COVID-19) is a worldwide emerging situation, which was initially reported in December …

The COVID-19 pandemic, caused by the rapid global spread of the novel coronavirus
(SARS-CoV-2), has caused healthcare systems to collapse and led to hundreds of …

Abstract Coronavirus disease 2019 (COVID-19) is a highly infectious epidemic disease that
has seriously affected human health worldwide. To date, however, there is still no definitive …

The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …

The outbreak of coronavirus disease 2019 (COVID-19) pandemic is quickly spreading all
over the world. This virus, which is called SARS-CoV-2, has infected tens of thousands of …

Mesenchymal (stem) stromal cells (MSC) can be a therapeutic alternative for COVID-19
considering their anti-inflammatory, regenerative, angiogenic, and even antimicrobial …